Rationale and design of the EMBRACE STEMI Study: A phase 2a, randomized, double-blind, placebo-controlled trial to evaluate the safety, tolerability and efficacy of intravenous Bendavia on reperfusion injury in patients treated with standard therapy including primary percutaneous coronary intervention and stenting for ST-segment elevation myocardial infarction
2013 ◽
Vol 165
(4)
◽
pp. 509-514.e7
◽
2005 ◽
Vol 14
(5)
◽
pp. 29
◽
2016 ◽
Vol 32
(4)
◽
pp. 351-357
◽
2013 ◽
Vol 2
(3)
◽
pp. 270-279
◽
2013 ◽
Vol 165
(4)
◽
pp. 515-522
◽